Percutaneous Vertebroplasty Versus Conservative Treatment of Pain
Primary Purpose
Pain, Osteoporosis, Fracture
Status
Completed
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
Poly methylmetacrylate, PMMA
Sponsored by
About this trial
This is an interventional treatment trial for Pain focused on measuring osteoporosis, vertebra, fracture, pain, percutaneous, vertebroplasty, polymethylmetacrylate
Eligibility Criteria
Inclusion Criteria: new pain in spine (within 6 months) x-ray verified low energy spinal fracture(s) Exclusion Criteria: less than 20% or more than 90% reduction of the vertebral height lack of pain at fracture level no need for continuous analgesic treatment patient no able to communicate general anaesthesia contraindicated MRI not possible coagulopathy (not adjustable) spondylitis discitis spinal metastasis
Sites / Locations
- Dep of Neuroradiology, Aarhus University Hospital
Outcomes
Primary Outcome Measures
Level of pain
Secondary Outcome Measures
Needs for analgetics, number of days at hospital, level of ADL
Full Information
NCT ID
NCT00203554
First Posted
September 16, 2005
Last Updated
March 26, 2008
Sponsor
University of Aarhus
1. Study Identification
Unique Protocol Identification Number
NCT00203554
Brief Title
Percutaneous Vertebroplasty Versus Conservative Treatment of Pain
Official Title
Percutaneous Vertebroplasty Versus Conservative Treatment of Pain: A Prospective, Randomized Controlled Study of Osteoporotic Fractures in the Spine
Study Type
Interventional
2. Study Status
Record Verification Date
March 2008
Overall Recruitment Status
Completed
Study Start Date
March 2004 (undefined)
Primary Completion Date
January 2008 (Actual)
Study Completion Date
January 2008 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
University of Aarhus
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose of this study is to compare the effect of vertebroplasty with that of traditional medical treatment in the treatment of painful vertebral fractures in osteoporotic patients.
Detailed Description
In vertebroplasty a bone cement is injected in one or more fractured vertebra. The indication is pain that needs high doses of analgesics.
The cement is a well known product called poly methyl metacrylate (PMMA) normally used fixate joint prosthesis.
Vertebroplasty is done in local anaesthesia. The treatment was introduced in 1984 in France and today thousands of patients have been treated worldwide, but so far no randomized controlled trials have been published.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pain, Osteoporosis, Fracture
Keywords
osteoporosis, vertebra, fracture, pain, percutaneous, vertebroplasty, polymethylmetacrylate
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
27 (Actual)
8. Arms, Groups, and Interventions
Intervention Type
Genetic
Intervention Name(s)
Poly methylmetacrylate, PMMA
Primary Outcome Measure Information:
Title
Level of pain
Time Frame
before treatment and day 1, day 3, day 10 and after 1, 3, 6 and 12 months.
Secondary Outcome Measure Information:
Title
Needs for analgetics, number of days at hospital, level of ADL
Time Frame
before treatment and day 1, day 3, day 10 and after 1, 3, 6 and 12 months.
10. Eligibility
Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
new pain in spine (within 6 months)
x-ray verified low energy spinal fracture(s)
Exclusion Criteria:
less than 20% or more than 90% reduction of the vertebral height
lack of pain at fracture level
no need for continuous analgesic treatment
patient no able to communicate
general anaesthesia contraindicated
MRI not possible
coagulopathy (not adjustable)
spondylitis
discitis
spinal metastasis
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Leif Sorensen, Consultant
Official's Role
Principal Investigator
Facility Information:
Facility Name
Dep of Neuroradiology, Aarhus University Hospital
City
Aarhus
ZIP/Postal Code
DK 8000
Country
Denmark
12. IPD Sharing Statement
Learn more about this trial
Percutaneous Vertebroplasty Versus Conservative Treatment of Pain
We'll reach out to this number within 24 hrs